Liquidia Corp (LQDA) Stock Price, Quote & News

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intr...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 919 328 4400

Fax: 919 328 4402

Website: www.liquidia.com

Address:

419 Davis Drive, Suite 100, Morrisville, United States

AbovetheGreenLine Aug. 19 at 6:52 PM

Swing Trade Buy on the Close for Liquidia Tech $LQDA. https://abovethegreenline.com/wp-content/uploads/2021/01/ST-1.jpg https://zpr.io/dfu7

0 · Reply

SteelerJon Aug. 19 at 3:12 PM

$LQDA 😂🏦🏦 We’ll see…

0 · Reply

msgu1021 Aug. 19 at 2:09 PM

$LQDA Stock lost 25% value in three days after earning. Now It's struggling stay in mid $70. Growth story is pretty much stagnant.

1 · Reply

Ms_P Aug. 19 at 1:17 PM

$LQDA the stock is obviously being manipulated (likely by sour grapes). 12 days remaining for clerks to change out, and the only material news is positive. We saw the same thing with $VRNA doubters until the revenues turned everyone into believers following by cherry on top $MRK BO. No reason to think same thing doesn’t happen here once legal hurdles cleared.

2 · Reply

KeelinTime Aug. 19 at 12:03 PM

$LQDA

0 · Reply

SteelerJon Aug. 19 at 11:25 AM

$LQDA Down pre market on 1 share traded. 😎🏦

0 · Reply

KeelinTime Aug. 19 at 1:04 AM

$LQDA

0 · Reply

msgu1021 Aug. 18 at 3:06 PM

$LQDA looks like this is stalled, feels vulnerable.

0 · Reply

KeelinTime Aug. 18 at 1:09 PM

$LQDA

0 · Reply

DoreenElliott136 Aug. 18 at 11:54 AM

$LQDA $UMAC $AEM $ANNX Liquidia advances inhaled therapies, UMAC remains focused on electric vertical-takeoff aircraft opportunities, Agnico Eagle benefits from gold prices and mining margins, and Annexon advances complement-targeted therapies. I'm watching regulatory milestones, aviation certification, gold prices, and clinical catalysts.

0 · Reply

Liquidia reports Q2 EPS 74c, consensus 84c

2026-08-17T09:07:18.000Z - 2 days ago

Liquidia downgraded to Market Perform from Outperform at LifeSci Capital

2026-08-17T08:22:43.000Z - 2 days ago

Liquidia price target raised to $108 from $62 at Wells Fargo

2026-08-17T08:19:39.000Z - 2 days ago

Liquidia price target raised to $92 from $79 at BofA

2026-08-17T07:44:52.000Z - 2 days ago

Liquidia price target raised to $106 from $68 at Raymond James

Aug 12, 2026, 8:30 AM EDT - 7 days ago

Liquidia Earnings Call Transcript: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 7 days ago

Liquidia Earnings release: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 7 days ago

Liquidia Quarterly report: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 7 days ago

Liquidia Slides: Q2 2026

Aug 12, 2026, 6:30 AM EDT - 7 days ago

Liquidia Corporation Reports Second Quarter 2026 Financial Results

Jul 29, 2026, 8:30 AM EDT - 21 days ago

Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026

2026-07-23T16:00:17.000Z - 27 days ago

Liquidia price target raised to $130 from $75 at H.C. Wainwright

UTHR

2026-06-29T10:30:39.000Z - 7 weeks ago

Liquidia downgraded to Neutral from Buy at BofA

2026-06-22T11:32:52.000Z - 2 months ago

Liquidia price target raised to $109 from $59 at BTIG

Jun 16, 2026, 4:30 PM EDT - 2 months ago

Liquidia Transcript: AGM 2026

Jun 11, 2026, 8:30 AM EDT - 2 months ago

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

2026-06-08T13:08:28.000Z - 2 months ago

Liquidia announces inclusion in S&P SmallCap 600 Index

Jun 8, 2026, 8:30 AM EDT - 2 months ago

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

2026-06-05T10:55:08.000Z - 2 months ago

Liquidia price target raised to $75 from $67 at H.C. Wainwright

2026-06-04T19:30:40.000Z - 2 months ago

Raymond James sees positive readthrough for Liquidia from Hikma v. Amarin

2026-06-04T16:09:07.000Z - 2 months ago

Liquidia rises 17.6%

Jun 3, 2026, 12:45 PM EDT - 2 months ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2026

May 27, 2026, 8:30 AM EDT - 3 months ago

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

May 19, 2026, 9:30 AM EDT - 3 months ago

Liquidia Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference

May 13, 2026, 11:40 AM EDT - 3 months ago

Liquidia Transcript: Bank of America Global Healthcare Conference 2026

2026-05-12T18:47:33.000Z - 3 months ago

Liquidia price target raised to $67 from $55 at H.C. Wainwright

2026-05-12T11:38:21.000Z - 3 months ago

Liquidia price target raised to $62 from $51 at Wells Fargo

2026-05-11T21:57:52.000Z - 3 months ago

Liquidia price target raised to $60 from $57 at Jefferies

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Earnings release: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Quarterly report: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Slides: Q1 2026

2026-05-11T11:28:55.000Z - 3 months ago

Liquidia reports Q1 EPS 52c, consensus 41c

May 11, 2026, 6:30 AM EDT - 3 months ago

Liquidia Corporation Reports First Quarter 2026 Financial Results

May 6, 2026, 8:30 AM EDT - 3 months ago

Liquidia Corporation to Participate in Upcoming Investor Conferences

May 4, 2026, 8:30 AM EDT - 3 months ago

Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Liquidia Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Liquidia Proxy statement: Proxy filing

Apr 15, 2026, 12:45 PM EDT - 4 months ago

Liquidia Transcript: 25th Annual Needham Virtual Healthcare Conference

Mar 5, 2026, 8:30 AM EST - 5 months ago

Liquidia Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

Liquidia Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

Liquidia Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

Liquidia Slides: Q4 2025

Mar 5, 2026, 6:30 AM EST - 5 months ago

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 26, 2026, 7:00 AM EST - 6 months ago

Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026

Jan 14, 2026, 8:15 PM EST - 7 months ago

Liquidia Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 8:15 PM EST - 7 months ago

Liquidia Slides: 44th Annual J.P. Morgan Healthcare Conference

Nov 18, 2025, 8:00 AM EST - 9 months ago

Liquidia Transcript: Jefferies London Healthcare Conference 2025

Nov 10, 2025, 4:15 PM EST - 10 months ago

Liquidia Transcript: UBS Global Healthcare Conference 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Slides: Q3 2025

Nov 3, 2025, 8:00 AM EST - 10 months ago

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Oct 28, 2025, 3:00 PM EDT - 10 months ago

Liquidia Transcript: R&D Day 2025

Oct 28, 2025, 3:00 PM EDT - 10 months ago

Liquidia Slides: FY 2025

Oct 27, 2025, 8:30 AM EDT - 10 months ago

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 7, 2025, 6:30 AM EDT - 11 months ago

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Sep 3, 2025, 3:45 PM EDT - 1 year ago

Liquidia Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Q2 2025

Aug 12, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jun 23, 2025, 4:34 PM EDT - 1 year ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 4, 2025, 11:05 AM EDT - 1 year ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2025

Jun 2, 2025, 6:30 AM EDT - 1 year ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

May 28, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Transcript: Status Update

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Status Update

May 23, 2025, 2:28 PM EDT - 1 year ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 13, 2025, 4:40 PM EDT - 1 year ago

Liquidia Transcript: BofA Securities 2025 Healthcare Conference

May 12, 2025, 6:00 AM EDT - 1 year ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q1 2025

May 8, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 2, 2025, 5:28 PM EDT - 1 year ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing

Apr 9, 2025, 8:45 AM EDT - 1 year ago

Liquidia Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 10:33 AM EDT - 1 year ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 9:30 AM EDT - 1 year ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Annual report: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q4 2024

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Liquidia Registration statement: Registration Filing

Mar 19, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Slides: FY 2025

Nov 19, 2024, 3:00 PM EST - 1 year ago

Liquidia Transcript: Stifel 2024 Healthcare Conference

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings Call Transcript: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Quarterly report: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings release: Q3 2024

Nov 13, 2024, 6:30 AM EST - 1 year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 7, 2024, 10:00 AM EDT - 2 years ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 2, 2024, 6:00 AM EDT - 2 years ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Sep 30, 2024, 8:00 AM EDT - 2 years ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 19, 2024, 1:30 PM EDT - 2 years ago

Liquidia Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 16, 2024, 9:41 AM EDT - 2 years ago

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

AbovetheGreenLine Aug. 19 at 6:52 PM

Swing Trade Buy on the Close for Liquidia Tech $LQDA. https://abovethegreenline.com/wp-content/uploads/2021/01/ST-1.jpg https://zpr.io/dfu7

0 · Reply

SteelerJon Aug. 19 at 3:12 PM

$LQDA 😂🏦🏦 We’ll see…

0 · Reply

msgu1021 Aug. 19 at 2:09 PM

$LQDA Stock lost 25% value in three days after earning. Now It's struggling stay in mid $70. Growth story is pretty much stagnant.

1 · Reply

Ms_P Aug. 19 at 1:17 PM

2 · Reply

KeelinTime Aug. 19 at 12:03 PM

$LQDA

0 · Reply

SteelerJon Aug. 19 at 11:25 AM

$LQDA Down pre market on 1 share traded. 😎🏦

0 · Reply

KeelinTime Aug. 19 at 1:04 AM

$LQDA

0 · Reply

msgu1021 Aug. 18 at 3:06 PM

$LQDA looks like this is stalled, feels vulnerable.

0 · Reply

KeelinTime Aug. 18 at 1:09 PM

$LQDA

0 · Reply

DoreenElliott136 Aug. 18 at 11:54 AM

0 · Reply

Gambaa Aug. 17 at 4:43 PM

$LQDA 🐂

0 · Reply

MrMulally Aug. 17 at 2:53 PM

$LQDA back on the saddle just like that!!! 🤣👏

0 · Reply

KeelinTime Aug. 17 at 2:43 PM

$LQDA

0 · Reply

SteelerJon Aug. 17 at 1:28 PM

$LQDA Now 1500 shares…stay

0 · Reply

SteelerJon Aug. 17 at 12:19 PM

$LQDA Down on 880 shares traded pre market. 😎🏦🏦 Still very

0 · Reply

Ceherring Aug. 16 at 12:52 PM

$LQDA

0 · Reply

KeelinTime Aug. 16 at 11:22 AM

$LQDA

0 · Reply

Ceherring Aug. 15 at 12:27 AM

$LQDA

0 · Reply

KeelinTime Aug. 14 at 8:22 PM

$LQDA

0 · Reply

SteelerJon Aug. 14 at 1:35 PM

$LQDA 😎🏦🏦 Still

0 · Reply

Gambaa Aug. 14 at 1:06 PM

$LQDA Happy Friday, lets bounce

0 · Reply

Ceherring Aug. 14 at 11:48 AM

$LQDA

0 · Reply

Market Cap	6.95B
Revenue (ttm)	158.32M
Net Income (ttm)	-68.92M
EPS (ttm)	N/A
PE Ratio	54.34
Forward PE	29.00
Profit Margin	-43.53%
Debt to Equity Ratio	0.90

Volume	741,095
Avg Vol	1,998,342
Day's Range	N/A - N/A
Shares Out	89.51M
Stochastic %K	13%
Beta	0.58
Analysts	Strong Sell
Price Target	$107.75